4-({(Z)-5-[(Z)-3-Ethoxy-4-hydroxybenzylidene]-3-methyl-4-oxo-1,3-thiazolidin-2-ylidene}amino)benzoic acid dimethylformamide monosolvate

by Paul Kosma, Edgar Selzer, Kurt Mereiter
Published 2012-12-01

NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.

by Alexandra Hebar, Barbara C Rütgen, Edgar Selzer
Published 2012-01-01

Experience in Intra-arterial Chemotherapy using Two Protocols for the Treatment of OSCC over Two Decades at the University Hospital Vienna

by Christina Eder-Czembirek, Sascha Rechinger, Gabriela Kornek, Edgar Selzer, Rudolf Seemann
Published 2018-10-01

Osteosarcoma of the jaw – experience at the Medical University Vienna and comparative study with international tumor registries

by Christina Eder-Czembirek, Doris Moser, Simone Holawe, Thomas Brodowicz, Jutta Ries, Irene Sulzbacher, Edgar Selzer
Published 2019-04-01

Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system

by Roland Grundtner, Klaus Dornmair, Ralf Dahm, Alexander Flügel, Naoto Kawakami, Manuel Zeitelhofer, Lucia Schoderboeck, Mikhail Nosov, Edgar Selzer, Martin Willheim, Michael Kiebler, Hartmut Wekerle, Hans Lassmann, Monika Bradl
Published 2007-12-01